Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse

• Published in: Inflammation
• Main Authors: Cai, Lu-Qiong, Li, Xiu-Chun, Wang, Yang-Yue, Chen, Yu-Xin, Zhu, Xia-Yan, Zuo, Zi-Yi, Si-Ma, Yi-Qun, Lin, Yi-Nuo, Li, Xiao-Kun, Huang, Xiao-Ying
• Format: Journal Article
• Language: English
• Published: United States 24.04.2024
• Subjects: fibroblast growth factor 21; inflammatory response; transcriptomics; fatty liver; aging; metabolomics and lipidomics
• ISSN: 0360-3997; 1573-2576
• DOI: 10.1007/s10753-024-02032-3

Aging is a physiological condition accomplished with persistent low-grade inflammation and metabolic disorders. FGF21 has been reported to act as a potent longevity determinant, involving inflammatory response and energy metabolism. In this study, we engineered aging FGF21 knockout mice of 36-40 weeks and observed that FGF21 deficiency manifests a spontaneous inflammatory response of lung and abnormal accumulation of lipids in liver. On one hand, inflamed state in lungs and increased circulating inflammatory cytokines were found in FGF21 knockout mice of 36-40 weeks. To evaluate the ability of FGF21 to suppress inflammation, a subsequent study found that FGF21 knockout aggravated LPS-induced pulmonary exudation and inflammatory infiltration in mice, while exogenous administration of FGF21 reversed these malignant phenotypes by enhancing microvascular endothelial junction. On the other hand, FGF21 knockout induces fatty liver in aging mice, characterized by excessive accumulation of triglycerides within hepatocytes. Further quantitative metabolomics and lipidomics analysis revealed perturbed metabolic profile in liver lacking FGF21, including disrupted glucose and lipids metabolism, glycerophospholipid metabolism, and amino acid metabolism. Taken together, this investigation reveals the protective role of FGF21 during aging by weakening the inflammatory response and balancing energy metabolism.